JP2014028787A5 - - Google Patents

Download PDF

Info

Publication number
JP2014028787A5
JP2014028787A5 JP2012199657A JP2012199657A JP2014028787A5 JP 2014028787 A5 JP2014028787 A5 JP 2014028787A5 JP 2012199657 A JP2012199657 A JP 2012199657A JP 2012199657 A JP2012199657 A JP 2012199657A JP 2014028787 A5 JP2014028787 A5 JP 2014028787A5
Authority
JP
Japan
Prior art keywords
keratinocytes
whitening agent
integrin
whitening
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012199657A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014028787A (ja
JP6113981B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012199657A priority Critical patent/JP6113981B2/ja
Priority claimed from JP2012199657A external-priority patent/JP6113981B2/ja
Publication of JP2014028787A publication Critical patent/JP2014028787A/ja
Publication of JP2014028787A5 publication Critical patent/JP2014028787A5/ja
Application granted granted Critical
Publication of JP6113981B2 publication Critical patent/JP6113981B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012199657A 2012-06-29 2012-09-11 スクリ−ニング方法 Active JP6113981B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012199657A JP6113981B2 (ja) 2012-06-29 2012-09-11 スクリ−ニング方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012146197 2012-06-29
JP2012146197 2012-06-29
JP2012199657A JP6113981B2 (ja) 2012-06-29 2012-09-11 スクリ−ニング方法

Publications (3)

Publication Number Publication Date
JP2014028787A JP2014028787A (ja) 2014-02-13
JP2014028787A5 true JP2014028787A5 (enExample) 2015-06-25
JP6113981B2 JP6113981B2 (ja) 2017-04-12

Family

ID=50201648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012199657A Active JP6113981B2 (ja) 2012-06-29 2012-09-11 スクリ−ニング方法

Country Status (1)

Country Link
JP (1) JP6113981B2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6763497B1 (ja) * 2020-03-25 2020-09-30 大正製薬株式会社 ミネラル代謝異常抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005013885A2 (en) * 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
JP5014569B2 (ja) * 2004-09-16 2012-08-29 オリザ油化株式会社 美肌用組成物
JP2008127357A (ja) * 2006-11-22 2008-06-05 Konan Kako Kk 皮膚外用剤組成物
JP5787285B2 (ja) * 2010-09-06 2015-09-30 公立大学法人大阪市立大学 線維芽細胞増殖促進剤、角化細胞遊走・増殖促進剤、エラスチン産生促進剤、ヒートショックタンパク質47産生促進剤、α−平滑筋アクチン(α−SMA)産生促進剤、及び光老化防止剤。

Similar Documents

Publication Publication Date Title
Castro et al. Ceramide: a simple sphingolipid with unique biophysical properties
JP2011037847A5 (enExample)
JP2012140442A5 (enExample)
CL2014003110A1 (es) Anticuerpo anti-fcrn; secuencias que lo codifican; vector; célula huésped; proceso de producción; composición farmacéutica que lo comprende; uso para el tratamiento de enfermedad autoinmune; y ensayo para probar la capacidad de un anticuerpo para bloquear la actividad de fcrn humano.
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
BR112013004124A2 (pt) peptídeo ou complexo de peptídeos ligando a alfa2 integrina e métodos e utilizações envolvendo os mesmos
JP2012050449A5 (enExample)
WO2014058976A3 (en) Biomarkers predictive for clinical response for glatiramer acetate
EP2628477A4 (en) COSMETICS IN THE FORM OF A WATER IN OIL EMULSION
WO2014096418A3 (en) Micrornas as therapeutics and biomarkers for epilepsy
MX387756B (es) Composiciones de matríces extracelulares.
WO2013011294A3 (en) Diagnosis of alzheimer's disease
WO2012131083A8 (en) Composition comprising perlite and a polymer bearing a carbosiloxane dendrimer-based unit
EP2803681A4 (en) VINYL ALCOHOL POLYMER AND METHOD OF MANUFACTURING THEREOF, AND COMPOSITION AND COATING WITH POLYVINYL ALCOHOL
FI3204767T3 (fi) Proteiinin hyödyllisyys in vivo -vaikutusten ennustamisessa
JP2012502289A5 (enExample)
JP2012527245A5 (enExample)
WO2012077898A3 (ko) 대사질환과 연관된 후각수용체 유전자 및 그의 용도
JP2014028787A5 (enExample)
JP2013099305A5 (enExample)
EP2690087A4 (en) NEW CRYSTAL FORMULA VII OF AGOMELATIN, MANUFACTURING METHOD AND USE THEREOF AND PHARMACEUTICAL COMPOSITION THEREWITH
JP2015180198A5 (enExample)
WO2011003665A3 (en) Method of treating hair
JP2014048235A5 (enExample)
JP2016063784A5 (enExample)